Published in Oncogene on June 26, 2003
A novel G-quadruplex-forming GGA repeat region in the c-myb promoter is a critical regulator of promoter activity. Nucleic Acids Res (2008) 1.49
HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT). Retrovirology (2007) 1.29
FOSL1 controls the assembly of endothelial cells into capillary tubes by direct repression of αv and β3 integrin transcription. Mol Cell Biol (2013) 1.00
Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling. J Cell Commun Signal (2009) 0.98
A transcriptome map of cellular transformation by the fos oncogene. Mol Cancer (2005) 0.86
Regulation of telomerase activity by interferon regulatory factors 4 and 8 in immune cells. Mol Cell Biol (2008) 0.83
Role of the AP-1 transcription factor FOSL1 in endothelial cells adhesion and migration. Cell Adh Migr (2013) 0.82
Global O-GlcNAc Levels Modulate Transcription of the Adipocyte Secretome during Chronic Insulin Resistance. Front Endocrinol (Lausanne) (2015) 0.82
A single nucleotide polymorphism in osteonectin 3' untranslated region regulates bone volume and is targeted by miR-433. J Bone Miner Res (2015) 0.81
Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1. Mol Cancer (2010) 0.76
Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell (2009) 3.45
PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Nat Cell Biol (2007) 3.26
Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility. J Cell Biol (2006) 1.76
Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood (2004) 1.38
Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs. Cell (2013) 1.35
Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest (2010) 1.32
HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT). Retrovirology (2007) 1.29
Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells. Mol Cell Biol (2011) 1.28
Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells. Genome Biol (2013) 1.22
Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity. Circ Res (2010) 1.14
Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells. Oncogene (2002) 1.11
Overexpression of transcription factor Sp1 leads to gene expression perturbations and cell cycle inhibition. PLoS One (2009) 1.09
An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment. Proc Natl Acad Sci U S A (2009) 1.07
Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1. Mol Endocrinol (2008) 1.06
FOSL1 controls the assembly of endothelial cells into capillary tubes by direct repression of αv and β3 integrin transcription. Mol Cell Biol (2013) 1.00
Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation. J Biol Chem (2006) 0.99
CK2-dependent phosphorylation of the E2 ubiquitin conjugating enzyme UBC3B induces its interaction with beta-TrCP and enhances beta-catenin degradation. Oncogene (2002) 0.99
Genome-wide profiling of mouse RNA secondary structures reveals key features of the mammalian transcriptome. Genome Biol (2014) 0.98
JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity. Cardiovasc Res (2006) 0.96
The utrophin gene is transcriptionally up-regulated in regenerating muscle. J Biol Chem (2002) 0.94
Vascular endothelial growth factor receptor-3 activity is modulated by its association with caveolin-1 on endothelial membrane. Biochemistry (2007) 0.90
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet J Rare Dis (2014) 0.89
Growth factor stimulation induces cell survival by c-Jun. ATF2-dependent activation of Bcl-XL. J Biol Chem (2010) 0.89
VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis. J Pathol (2009) 0.89
MREdictor: a two-step dynamic interaction model that accounts for mRNA accessibility and Pumilio binding accurately predicts microRNA targets. Nucleic Acids Res (2013) 0.89
c-ABL modulates MAP kinases activation downstream of VEGFR-2 signaling by direct phosphorylation of the adaptor proteins GRB2 and NCK1. Angiogenesis (2012) 0.88
Dysregulation of ezrin phosphorylation prevents metastasis and alters cellular metabolism in osteosarcoma. Cancer Res (2011) 0.87
VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation. Proc Natl Acad Sci U S A (2011) 0.86
Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin-like growth factor I. Int J Cancer (2009) 0.85
Beta-catenin inversely regulates vascular endothelial growth factor-D mRNA stability. J Biol Chem (2003) 0.85
The characterization of a novel monoclonal antibody against CD93 unveils a new antiangiogenic target. Oncotarget (2014) 0.83
Morphogenesis of human endothelial cells is inhibited by DAB2 via Src. FEBS Lett (2008) 0.83
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4. FEBS Lett (2008) 0.82
Characterization of the ubinuclein protein as a new member of the nuclear and adhesion complex components (NACos). Biol Cell (2009) 0.82
v-Jun downregulates the alpha 2 (I) collagen target gene indirectly through Sp1/3. Oncogene (2005) 0.81
Snai1 promotes ESC exit from the pluripotency by direct repression of self-renewal genes. Stem Cells (2015) 0.80
An apical actin-rich domain drives the establishment of cell polarity during cell adhesion. Histochem Cell Biol (2012) 0.78
Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells. Biochem Biophys Res Commun (2008) 0.78
VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues. Leuk Lymphoma (2007) 0.77